Effect of CYP2C9 Polymorphisms on the Pharmacokinetics of Indomethacin During Pregnancy
European Journal of Drug Metabolism and Pharmacokinetics(2019)
Abstract
Although our results are limited by sample size and are not statistically significant, these data suggest that certain genetic polymorphisms of CYP2C9 may lead to an increased metabolic ratio and an increase in the clearance of indomethacin. More data are needed to assess the impact of CYP2C9 genotype on the effectiveness of indomethacin as a tocolytic agent.
MoreTranslated text
Key words
cyp2c9 polymorphisms,indomethacin,pharmacokinetics,pregnancy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined